Daniel Steinberg to Treatment Outcome
This is a "connection" page, showing publications Daniel Steinberg has written about Treatment Outcome.
Connection Strength
0.738
-
Aortic Diastolic Blood Pressure and Widened Pulse Pressure as Post-Transcatheter Aortic Valve Implantation Measurements. Cardiovasc Revasc Med. 2022 06; 39:26-27.
Score: 0.085
-
Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud? in patients with stroke or transient ischemic attack. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1262-7.
Score: 0.052
-
Advances in transcatheter valve therapies. J Cardiovasc Transl Res. 2014 Jun; 7(4):375-86.
Score: 0.049
-
Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
Score: 0.043
-
Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
Score: 0.037
-
Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
Score: 0.034
-
Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008 Jul 15; 102(2):160-4.
Score: 0.033
-
Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
Score: 0.030
-
Hemodynamic Impact of MitraClip Procedure for Systemic Tricuspid Regurgitation in Congenitally Corrected Transposition of Great Arteries: A Case Report. Cardiovasc Revasc Med. 2021 07; 28S:114-117.
Score: 0.019
-
SCAI expert consensus statement update on best practices for transradial angiography and intervention. Catheter Cardiovasc Interv. 2020 02; 95(2):245-252.
Score: 0.018
-
Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
Score: 0.016
-
Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. J Cardiovasc Comput Tomogr. 2016 Sep-Oct; 10(5):377-83.
Score: 0.014
-
Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):e21-2.
Score: 0.012
-
Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):541-6.
Score: 0.012
-
Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):838-45.
Score: 0.011
-
Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013 Feb; 81(2):335-9.
Score: 0.011
-
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
Score: 0.011
-
Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
Score: 0.011
-
New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009 Nov 15; 74(6):889-95.
Score: 0.009
-
Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
Score: 0.009
-
Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
Score: 0.009
-
Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):612-7.
Score: 0.009
-
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
Score: 0.009
-
Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol. 2009 Feb 15; 103(4):496-500.
Score: 0.009
-
Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
Score: 0.009
-
Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
Score: 0.009
-
Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention. J Interv Cardiol. 2009 Feb; 22(1):61-7.
Score: 0.009
-
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
Score: 0.009
-
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009 Mar 01; 103(5):653-8.
Score: 0.009
-
Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
Score: 0.008
-
Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions. Am J Cardiol. 2008 Nov 01; 102(9):1175-81.
Score: 0.008
-
Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
Score: 0.008
-
Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol. 2008 Sep 01; 102(5):535-40.
Score: 0.008
-
Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern. Am J Cardiol. 2008 Sep 01; 102(5):621-4.
Score: 0.008
-
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
Score: 0.008
-
Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008 Aug 01; 102(3):287-91.
Score: 0.008
-
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2008 Aug 01; 102(3):292-7.
Score: 0.008
-
Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008 Jun 01; 101(11):1544-9.
Score: 0.008
-
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus. Am J Cardiol. 2008 May 01; 101(9):1253-8.
Score: 0.008
-
Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol. 2008 Feb 15; 101(4):452-6.
Score: 0.008
-
Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
Score: 0.008
-
Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome? Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):826-31.
Score: 0.008
-
Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007 Oct; 20(5):307-13.
Score: 0.008
-
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007 Sep 11; 116(11 Suppl):I200-6.
Score: 0.008
-
Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
Score: 0.008
-
Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
Score: 0.008
-
Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8.
Score: 0.007